PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
GHC vs. WST
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between GHC and WST is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

GHC vs. WST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Graham Holdings Company (GHC) and West Pharmaceutical Services, Inc. (WST). The values are adjusted to include any dividend payments, if applicable.

0.00%2,000.00%4,000.00%6,000.00%8,000.00%10,000.00%12,000.00%JulyAugustSeptemberOctoberNovemberDecember
755.92%
12,345.55%
GHC
WST

Key characteristics

Sharpe Ratio

GHC:

1.02

WST:

-0.13

Sortino Ratio

GHC:

1.66

WST:

0.09

Omega Ratio

GHC:

1.20

WST:

1.01

Calmar Ratio

GHC:

2.08

WST:

-0.12

Martin Ratio

GHC:

5.70

WST:

-0.25

Ulcer Index

GHC:

5.30%

WST:

19.57%

Daily Std Dev

GHC:

29.63%

WST:

38.73%

Max Drawdown

GHC:

-67.54%

WST:

-55.52%

Current Drawdown

GHC:

-8.59%

WST:

-29.19%

Fundamentals

Market Cap

GHC:

$3.88B

WST:

$24.21B

EPS

GHC:

$51.18

WST:

$6.75

PE Ratio

GHC:

17.48

WST:

49.52

PEG Ratio

GHC:

0.00

WST:

6.24

Total Revenue (TTM)

GHC:

$4.71B

WST:

$2.88B

Gross Profit (TTM)

GHC:

$1.31B

WST:

$1.00B

EBITDA (TTM)

GHC:

$706.26M

WST:

$743.90M

Returns By Period

In the year-to-date period, GHC achieves a 27.18% return, which is significantly higher than WST's -5.66% return. Over the past 10 years, GHC has underperformed WST with an annualized return of 6.30%, while WST has yielded a comparatively higher 20.49% annualized return.


GHC

YTD

27.18%

1M

-3.18%

6M

23.91%

1Y

29.63%

5Y*

7.39%

10Y*

6.30%

WST

YTD

-5.66%

1M

3.28%

6M

-0.28%

1Y

-6.41%

5Y*

17.32%

10Y*

20.49%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

GHC vs. WST - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Graham Holdings Company (GHC) and West Pharmaceutical Services, Inc. (WST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for GHC, currently valued at 1.02, compared to the broader market-4.00-2.000.002.001.02-0.13
The chart of Sortino ratio for GHC, currently valued at 1.66, compared to the broader market-4.00-2.000.002.004.001.660.09
The chart of Omega ratio for GHC, currently valued at 1.20, compared to the broader market0.501.001.502.001.201.01
The chart of Calmar ratio for GHC, currently valued at 2.08, compared to the broader market0.002.004.006.002.08-0.12
The chart of Martin ratio for GHC, currently valued at 5.70, compared to the broader market-5.000.005.0010.0015.0020.0025.005.70-0.25
GHC
WST

The current GHC Sharpe Ratio is 1.02, which is higher than the WST Sharpe Ratio of -0.13. The chart below compares the historical Sharpe Ratios of GHC and WST, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.002.50JulyAugustSeptemberOctoberNovemberDecember
1.02
-0.13
GHC
WST

Dividends

GHC vs. WST - Dividend Comparison

GHC's dividend yield for the trailing twelve months is around 0.78%, more than WST's 0.24% yield.


TTM20232022202120202019201820172016201520142013
GHC
Graham Holdings Company
0.78%0.95%1.05%0.96%1.09%0.87%0.83%0.91%0.95%1.77%1.18%0.00%
WST
West Pharmaceutical Services, Inc.
0.24%0.22%0.31%0.15%0.23%0.41%0.58%0.54%0.58%0.75%0.77%0.78%

Drawdowns

GHC vs. WST - Drawdown Comparison

The maximum GHC drawdown since its inception was -67.54%, which is greater than WST's maximum drawdown of -55.52%. Use the drawdown chart below to compare losses from any high point for GHC and WST. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-8.59%
-29.19%
GHC
WST

Volatility

GHC vs. WST - Volatility Comparison

Graham Holdings Company (GHC) has a higher volatility of 8.34% compared to West Pharmaceutical Services, Inc. (WST) at 6.80%. This indicates that GHC's price experiences larger fluctuations and is considered to be riskier than WST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%JulyAugustSeptemberOctoberNovemberDecember
8.34%
6.80%
GHC
WST

Financials

GHC vs. WST - Financials Comparison

This section allows you to compare key financial metrics between Graham Holdings Company and West Pharmaceutical Services, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab